The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China's CanSino Biologics and Russia's Gamaleya Institute have been studied for decades, but are still not widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback